Pilot study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, ABCB1 genes expression in peripheral blood leukocytes in schizophrenic patients with metabolic syndrome
- Authors: Boiko A.S.1, Paderina D.Z.1, Mikhalitskaya E.V.1, Kornetova E.G.1,2, Bokhan N.A.1,3, Ivanova S.A.1,2
- 
							Affiliations: 
							- Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
- Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation
- National Research Tomsk State University
 
- Issue: Vol 41, No 1 (2024)
- Pages: 37-43
- Section: Clinical Neurochemistry
- URL: https://cardiosomatics.ru/1027-8133/article/view/653914
- DOI: https://doi.org/10.31857/S1027813324010052
- EDN: https://elibrary.ru/GZDJUZ
- ID: 653914
Cite item
Abstract
Many individuals with schizophrenia also suffer from metabolic syndrome (MetS), which is a major risk factor for the development of cardiovascular diseases associated with a heavy burden of disease, as well as with premature death of patients. This study investigated the expression of 7 genes potentially important for the development of metabolic syndrome. QuantiGene Plex 2.0 technology was used to measure how 7 studied genes (DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, ABCB1 (MDR1)) were expressed by leukocytes in 60 recently admitted patients with schizophrenia who had been on treatment with antipsychotic drugs. The preliminary results of our study show a change in the expression of the FTO gene in schizophrenia male with metabolic disorders, however, further studies are needed to determine the role of disturbances in the expression of this gene in the development of the metabolic syndrome in patients with schizophrenia.
Keywords
Full Text
 
												
	                        About the authors
A. S. Boiko
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
D. Z. Paderina
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
E. V. Mikhalitskaya
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
														Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk						
E. G. Kornetova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation
														Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk; Tomsk						
N. A. Bokhan
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; National Research Tomsk State University
														Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk; Tomsk						
S. A. Ivanova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation
							Author for correspondence.
							Email: ivanovaniipz@gmail.com
				                					                																			                												                	Russian Federation, 							Tomsk; Tomsk						
References
- Sugawara N., Yasui-Furukori N., Sato Y., Umeda T., Kishida I., Yamashita H., Saito M., Furukori H., Nakagami T., Hatakeyama M., Nakaji S., Kaneko S. // Schizophr. Res. 2010. V. 123 (2–3). P. 244–250.
- Lee J., Nurjono M., Wong A., Salim A. // Ann. Acad. Med. Singap. 2012. V. 41(10). P. 457–462.
- Kornetova E.G., Kornetov A.N., Mednova I.A., Goncharova A.A., Gerasimova V.I., Pozhidaev I.V., Boiko A.S., Semke A.V., Loonen A.J.M., Bokhan N.A., Ivanova S.A. // Front. Psychiatry. 2021. V. 12. P. 661174.
- Tian Y., Liu D., Wang D., Wang J., Xu H., Dai Q., Andriescue E.C., Wu H.E., Xiu M., Chen D., Wang L., Chen Y., Yang R., Wu A., Wei C.W., Zhang X. // Schizophr. Res. 2020. V. 215. P. 270–276.
- Sugai T., Suzuki Y., Yamazaki M., Shimoda K., Mori T., Ozeki Y., Matsuda H., Sugawara N., Yasui-Furukori N., Minami Y., Okamoto K., Sagae T., Someya T. // PLoS One. 2016. V. 11(11). e0166429.
- Sneller M.H., de Boer N., Everaars S., Schuurmans M., Guloksuz S., Cahn W., Luykx J.J. // Front. Psychiatry. 2021. V. 12. P. 625935.
- Boiko A.S., Mednova I.A., Kornetova E.G., Goncharova A.A., Semke A.V., Bokhan N.A., Ivanova S.A. // J. Pers. Med. 2022. V. 12. P. 1655.
- Pinto J.A.F., Freitas P.H.B., Nunes F.D.D., Granjeiro P.A., Santos L.L.D., Machado R.M. // Rev. Lat. Am. Enfermagem. 2018. V. 26. e2983.
- Kegeles L.S., Abi-Dargham A., Frankle W.G., Gil R., Cooper T.B., Slifstein M. // Arch. Gen. Psychiatry. 2010. V. 67(3). P. 231–239.
- Paderina D.Z., Boiko A.S., Pozhidaev I.V., Bocharova A.V., Mednova I.A., Fedorenko O.Y., Kornetova E.G., Loonen A.J.M., Semke A.V., Bokhan N.A., Ivanova S.A. // J. Pers. Med. 2021. V. 11(3). P. 181.
- Chang T.T., Chen S.L., Chang Y.H., Chen P.S., Chu C.H., Chen S.H., Huang S.Y., Tzeng N.S., Wang L.J., Wang T.Y., Li C.L., Chung Y.L., Hsieh T.H., Lee I.H., Chen K.C., Yang Y.K., Hong J.S., Lu R.B., Lee S.Y. // Medicine (Baltimore). 2016. V. 95(24). e3488.
- Lee J.H., Cho J. // Sleep Med. Clin. 2022. V. 17. P. 111–116.
- Jin H., Meyer J.M., Mudaliar S., Jeste D.V. // Schizophr. Res. 2008. V. 100. P. 70–85.
- Goetz R.L., Miller B.J. // Schizophr. Res. 2019. V. 206. P. 21–26.
- Koop S., Oster H. // The FEBS Journal. 2022. V. 289. P. 6543–6558.
- Davis J. // Brain Research. 2018. V. 1693 (B). P. 154–158.
- Zhou Y., Kong Y., Fan W., Tao T., Xiao Q., Li N., Zhu X. // Biomed. Pharmacother. 2020. V. 131. P. 110731.
- He P.C., He C. // EMBO J. 2021. V. 40(3). e105977.
- Fischer J., Koch L., Emmerling C., Vierkotten J., Peters T., Brüning J.C., Rüther U. // Nature. 2009. V. 458(7240). P. 894–898.
- Gao X., Shin Y.H., Li M., Wang F., Tong Q., Zhang P. // PLoS One. 2010. V. 5(11). e14005.
- Church C., Moir L., McMurray F., Girard C., Banks G.T., Teboul L., Wells S., Brüning J.C., Nolan P.M., Ashcroft F.M., Cox R.D. // Nat. Genet. 2010. V. 42(12). P. 1086–1092.
- Vasudev K., Choi Y.H., Norman R., Kim R.B., Schwarz U.I. // Can. J. Psychiatry. 2017. V. 62(2). P. 138–149.
- Boiko A.S., Pozhidaev I.V., Paderina D.Z., Mednova I.A., Goncharova A.A., Fedorenko O.Y., Kornetova E.G., Semke A.V., Bokhan N.A., Loonen A.J.M., Ivanova S.A. // Genes. 2022. V. 13. P. 844.
- Gregoor J.G., van der Weide J., Mulder H., Cohen D., van Megen H.J., Egberts A.C., Heerdink E.R. // J. Clin. Psychopharmacol. 2009. V. 29(1). P. 21–25.
- Banks W.A. // Compr. Physiol. 2021. V. 11(4). P. 2351–2369.
- Wada N., Hirako S., Takenoya F., Kageyama H., Okabe M., Shioda S. // J. Chem. Neuroanat. 2014. V. 61–62. P. 191–199.
- Yan R., Cao P., Song W., Li Y., Wang T., Qian H., Yan C., Yan N. // Cell Rep. 2021. V. 35. P. 109299.
- Dong X.Y., Tang S.Q. // Peptides. 2010. V. 31. P. 2145–2150.
- Hayes J.D., Strange R.C. // Pharmacology. 2000. V. 61. P. 154–166.
- Park Y.M., Lee H.J., Kang S.G., Choi J.E., Cho J.H., Kim L. // Psychiatry Investig. 2010. V. 7(2). P. 147–152.
- Fridlyand L.E., Philipson L.H. // Diabetes Obes. Metab. 2006. V. 8. P. 136–145.
- Houstis N., Rosen E.D., Lander E.S. // Nature. 2006. V. 440. P. 944–948.
- Lee Y.S., Kim A.Y., Choi J.W., Kim M., Yasue S., Son H.J., Masuzaki H., Park K.S., Kim J.B. // Mol. Endocrinol. 2008. V. 22. P. 2176–2189.
- Marzolini C., Paus E., Buclin T., Kim R.B. // Clin. Pharmacol. Ther. 2004. V. 75(1). P. 13–33.
- Macdonald N., Gledhill A. // Arch. Toxicol. 2007. V. 81(8). P. 553–563.
- Geers L.M., Pozhidaev I.V., Ivanova S.A., Freidin M.B., Schmidt A.F., Cohen D., Boiko A.S., Paderina D.Z., Fedorenko O.Y., Semke A.V., Bokhan N.A., Wilffert B., Kosterink J.G.W., Touw D.J., Loonen A.J.M. // Br.J. Clin. Pharmacol. 2020. V. 86(9). P. 1827–1835.
- Geers L.M., Ochi T., Vyalova N.M., Losenkov I.S., Paderina D.Z., Pozhidaev I.V., Simutkin G.G., Bokhan N.A., Wilffert B., Touw D.J., Loonen A.J.M., Ivanova S.A. // Hum. Psychopharmacol. 2022. V. 37(3). e2826.
- Ding H., Xie M., Wang J., Ouyang M., Huang Y., Yuan F., Jia Y., Zhang X., Liu N., Zhang N. // J. Psychiatr. Res. 2023. V. 159. P. 185–195.
- Chang R., Huang Z., Zhao S., Zou J., Li Y., Tan S. // Biomed. Res. Int. 2022. V. 2022. P. 2677312.
- Boiko A.S., Pozhidaev I.V., Paderina D.Z., Bocharova A.V., Mednova I.A., Fedorenko O.Y., Kornetova E.G., Loonen A.J.M., Semke A.V., Bokhan N.A., Ivanova S.A. // Pharmgenomics. Pers. Med. 2021. V. 14. P. 1123–1131.
- Ortega-Azorín C., Coltell O., Asensio E.M., Sorlí J.V., González J.I., Portolés O., Saiz C., Estruch R., Ramírez-Sabio J.B., Pérez-Fidalgo A., Ordovas J.M., Corella D. // Nutrients. 2019. V. 11(11). P. 2751.
- Pirastu N., Cordioli M., Nandakumar P., Mignogna G., Abdellaoui A., Hollis B., Kanai M., Rajagopal V.M., Parolo P.D.B., Baya N., Carey C.E., Karjalainen J., Als T.D., Van der Zee M.D., Day F.R., Ong K.K., FinnGen Study, 23andMe Research Team, iPSYCH Consortium, Morisaki T., de Geus E., Bellocco R., Okada Y., Børglum A.D., Joshi P., Auton A., Hinds D., Neale B.M., Walters R.K., Nivard M.G., Perry J.R.B., Ganna A. // Nat Genet. 2021. V. 53(5). P. 663–671.
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
									

 
  
  
  Email this article
			Email this article 

 Open Access
		                                Open Access Access granted
						Access granted